Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;38(3):126-34.
doi: 10.5653/cerm.2011.38.3.126. Epub 2011 Sep 30.

An update of preimplantation genetic diagnosis in gene diseases, chromosomal translocation, and aneuploidy screening

Affiliations

An update of preimplantation genetic diagnosis in gene diseases, chromosomal translocation, and aneuploidy screening

Li-Jung Chang et al. Clin Exp Reprod Med. 2011 Sep.

Abstract

Preimplantation genetic diagnosis (PGD) is gradually widely used in prevention of gene diseases and chromosomal abnormalities. Much improvement has been achieved in biopsy technique and molecular diagnosis. Blastocyst biopsy can increase diagnostic accuracy and reduce allele dropout. It is cost-effective and currently plays an important role. Whole genome amplification permits subsequent individual detection of multiple gene loci and screening all 23 pairs of chromosomes. For PGD of chromosomal translocation, fluorescence in-situ hybridization (FISH) is traditionally used, but with technical difficulty. Array comparative genomic hybridization (CGH) can detect translocation and 23 pairs of chromosomes that may replace FISH. Single nucleotide polymorphisms array with haplotyping can further distinguish between normal chromosomes and balanced translocation. PGD may shorten time to conceive and reduce miscarriage for patients with chromosomal translocation. PGD has a potential value for mitochondrial diseases. Preimplantation genetic haplotyping has been applied for unknown mutation sites of single gene disease. Preimplantation genetic screening (PGS) using limited FISH probes in the cleavage-stage embryo did not increase live birth rates for patients with advanced maternal age, unexplained recurrent abortions, and repeated implantation failure. Polar body and blastocyst biopsy may circumvent the problem of mosaicism. PGS using blastocyst biopsy and array CGH is encouraging and merit further studies. Cryopreservation of biopsied blastocysts instead of fresh transfer permits sufficient time for transportation and genetic analysis. Cryopreservation of embryos may avoid ovarian hyperstimulation syndrome and possible suboptimal endometrium.

Keywords: Array Comparative Genomic Hybridization; Human; Preimplantation Genetic Diagnosis; Preimplantation Genetic Screening; Single Nucleotide Polymorphisms Array; Vitrification; Whole Genome Amplification.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Similar articles

Cited by

References

    1. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990;344:768–770. - PubMed
    1. Geraedts JP, De Wert GM. Preimplantation genetic diagnosis. Clin Genet. 2009;76:315–325. - PubMed
    1. Simpson JL. Preimplantation genetic diagnosis at 20 years. Prenat Diagn. 2010;30:682–695. - PubMed
    1. Chen YL, Hung CC, Lin SY, Fang MY, Tsai YY, Chang LJ, et al. Successful application of the strategy of blastocyst biopsy, vitrification, whole genome amplification, and thawed embryo transfer for preimplantation genetic diagnosis of neurofibromatosis type 1. Taiwan J Obstet Gynecol. 2011;50:74–78. - PubMed
    1. Chen SU, Su YN, Fang MY, Chang LJ, Tsai YY, Lin LT, et al. PGD of beta-thalassaemia and HLA haplotypes using OmniPlex whole genome amplification. Reprod Biomed Online. 2008;17:699–705. - PubMed